Consensus for the use of fibrates in the treatment of dyslipoproteinemia and coronary heart disease

被引：0
|
作者：
Fruchart, JC
Brewer, B
Leitersdorf, E
Brochier, M
Brown, G
Calvo, C
Carmena, R
Ceska, R
Loy-Soong, WC
Davignon, J
Gotto, A
Grundy, S
Hamsten, A
Keech, A
Matsuzawa, Y
Patch, JR
Paoletti, R
Raslova, K
Smirnov, V
Steiner, G
Thompson, G
Zhu, JR
机构：
[1] Inst Pasteur, INSERM, U325, F-59019 Lille, France
[2] NHLBI, NIH, Bethesda, MD 20892 USA
[3] Hadassah Univ Hosp, Div Med, IL-91120 Jerusalem, Israel
来源：
AMERICAN JOURNAL OF CARDIOLOGY | 1998年 / 81卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
The hypolipidemic action of fibrates has recently been shown to involve the activation of peroxisome proliferator activated receptors establishing a molecular mechanism for this class of drugs. Increasing clinical trial evidence supports the efficacy of fibrates in the treatment of dyslipoproteinemias, particularly in patients with hypertriglyceridemia and low high-density lipoproteins.
引用
收藏
页码：912 / +
页数：7
相关论文
共 50 条
  • [1] Treatment of hyperlipidaemia as a risk factor for coronary heart disease: the role of fibrates
    Linssen, R
    HOSPITAL MEDICINE, 1999, 60 (04): : 298 - 301
  • [2] APOLIPOPROTEINS, DYSLIPOPROTEINEMIA AND PREMATURE CORONARY HEART-DISEASE
    HAMSTEN, A
    ACTA MEDICA SCANDINAVICA, 1988, 223 (05): : 389 - 403
  • [3] Dyslipoproteinemia and coronary disease
    Raos, V
    Strujuc, BJ
    ANGIOLOGY, 2002, 53 (05) : 557 - 562
  • [4] A need to redefine the consensus on the use of statins in coronary heart disease prevention
    Fruchart, JC
    EUROPEAN HEART JOURNAL, 2000, 21 (19) : 1572 - 1573
  • [5] Role of fibrates in reducing coronary risk: a UK consensus
    Mikhailidis, DP
    CURRENT MEDICAL RESEARCH AND OPINION, 2004, 20 (02) : 241 - 247
  • [6] USE OF ESTROGEN THERAPY IN TREATMENT OF CORONARY HEART DISEASE
    ROBINSON, RW
    GERIATRICS, 1965, 20 (02) : 87 - &
  • [7] Fibrates and high-dose statins to prevent coronary heart disease events
    Jones P.H.
    Current Cardiology Reports, 1999, 1 (3) : 223 - 224
  • [8] ATHEROGENIC DYSLIPOPROTEINEMIA IN ADOLESCENTS - ASSOCIATION WITH CORONARY HEART-DISEASE IN FATHERS, POSSIBILITY OF PREDICTION
    METELSKAYA, VA
    AINGORN, ED
    MASLENNIKOVA, GY
    DOROFEEVA, TG
    GORCHAKOVA, NN
    SIPYAGINA, AE
    RUZHANSKAYA, TV
    GRIGORYEVA, IV
    OLFERYEV, AM
    BELOKON, NA
    PEROVA, NV
    KARDIOLOGIYA, 1989, 29 (09) : 28 - 34
  • [9] PLATELET-FUNCTION AND VASCULAR WALL ANTIAGGREGATION ACTIVITY IN DYSLIPOPROTEINEMIA AND CORONARY HEART-DISEASE
    MIKHAILOVA, IA
    LIPOVETSKY, BM
    MAGRACHEVA, EY
    GUREVICH, VS
    TERAPEVTICHESKII ARKHIV, 1989, 61 (02) : 101 - 104
  • [10] CONSENSUS OR NONSENSUS CONFERENCES ON CORONARY HEART-DISEASE
    OLIVER, MF
    LANCET, 1985, 1 (8437): : 1087 - 1089
12345